29. Chandrani P, Kulkarni V, Iyer P, Upadhyay P, Chaubal R, Das P, Mulherkar R, Singh R, Dutt A. , NGS Based Approach to Determine the Presence of HPV and Their Sites of Integration in Human Cancer Genome. Br J Cancer. 2015 Apr.
[READ] [SUMMARY]
   This work was featured here: [Wellcome Trust DBT]
30. Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A,Prasannan P, Singh A, Iyer A, Singh A, Upadhyay P, Nair NK, Mishra PK, Dutt A. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci. 2015 Mar;40(1):91-111.
[READ] [SUMMARY]
31. Barreto SG, Barreto M, Chaubal R, Dutt A. The fight against cancer: Is it worthwhile? Indian J Med Paediatr Oncol. 2015 Apr-Jun;36(2):85-6. doi:10.4103/0971-5851.158833.
[READ] [SUMMARY]
32. Ramteke MP, Patel KJ, Godbole M,Maulik Vyas, Kunal Karve, Anuradha Choughule, Dutt A. CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons [version 2; referees: 2 approved, 1 approved with reservations]. F1000Research 2015, 4:160 (doi: 10.12688/f1000research.6663.1)
[READ] [SUMMARY]
33. Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram GV, Oak N, Singh A, Chaubal R, Ramteke M, Gupta S, Dutt A. Integrated genomics approach to identify biologically relevant alterations in fewer samples. BMC Genomics. 2015 Nov 14;16(1):936. doi: 10.1186/s12864-015-2138-4.
[READ] [SUMMARY]
34. Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR, Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. Infect Agent Cancer. 2016 Mar 3;11:12.
[READ] [SUMMARY]
   This work was featured here:
   [IndiaBioscience][Wellcome Trust DBT]
35. Barreto SG and Dutt A. To improve outcomes of gallbladder cancer we need to better understand it! Hepatobiliary Surg Nutr 2016;5(4):379-381. doi: 10.21037/hbsn.2016.05.06
[READ]
36. Kaur E, Sahu A, Hole AR, Rajendra J, Chaubal R, Gardi N, Dutt A., Moiyadi A, Krishna CM, Dutt S. Unique spectral markers discern recurrent Glioblastoma cells from heterogeneous parent population.Sci Rep. 2016 May 25;6:26538. doi: 10.1038/srep26538.
[READ] [SUMMARY]
37. Upadhyay P, Gardi N*, Desai S*, Sahoo B, Singh A,Togar T, Iyer P, Prasad R, Chandrani P, Gupta S, Dutt A. TMC-SNPdb: an Indian germline variant dataset derived from whole exome sequence. Database, 2016, 1–8. doi: 10.1093/database/baw104
[READ] [SUMMARY]
38. Upadhyay P*, Nair S*, Kaur E, Aich J, Dani P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, Prasad R, Kannan S, Agarwal A, Kane S, Gupta S, Dutt S, Dutt A. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget 2016
[READ] [SUMMARY]
39. Bharat Rekhi*, Pawan Upadhyay*, Manoj P. Ramteke Dutt A. MYOD1 (L122R) Mutations Are Associated with Spindle cell and Sclerosing Rhabdomyosarcomas with Aggressive Clinical Outcomes. Modern Pathology, 2016
[READ] [SUMMARY]
40. Chandrani P*, Prabhash K*, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, Noronha V, Patil V, Ramaswamy A, Karpe A, Thorat R, Chaudhari P, Ingle A, Choughule A, Dutt A. Drug-sensitive FGFR3 mutations in lung adenocarcinoma. Annals of oncology, 2016
[READ] [SUMMARY]
   This work was featured here:
   [natureINDIA] [IndiaBioscience] [wellcomedbt] [Indian Express]
41. Mittra I, Samant U, Sharma S, Raghuram GV, Saha T, Tidke P, Pancholi N, Gupta D, Prasannan P, Gaikwad A, Gardi N, Chaubal R, Upadhyay P, Pal K, Rane B, Shaikh A, Salunkhe S, Dutt S, Mishra PK, Khare NK, Nair NK, Dutt A . Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death Discovery, 2017.3, 17015; doi:10.1038/cddiscovery.2017.15
[READ] [SUMMARY]
42. Bhat S, Gardi N, Hake S, Kotian N, Sawant S, Kannan S, Parmar V, Desai S, Dutt A, Joshi NN . Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients. Research and Clinical Oncology . 2017 May 3. doi: 10.1007/s00432-017-2431-5
[READ]
43. Noronha V, Chougule A, Patil VM, Joshi A, Kumar V, Philip DSJ, Banavasi S, Dutt A, Prabhash K . Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment. OncoTargets and Therapy . 2017
[READ]
44. Upadhyay P, Gardi N, Desai S, Chandrani P, Joshi A, Dharavath B, Arora P, Bal M, Nair S, Dutt A. Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 as a candidate to predict metastases. Oral Oncology 73:56-64, 2017
[READ] [SUMMARY]
   This work was featured here:
   [natureINDIA] [IndiaBioscience] [wellcomedbt] [The Hindu]
45. Godbole M, Tiwary K, Badwe R, Gupta S, Dutt A. Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status. Cellular Oncology. 2017
[READ] [SUMMARY]
   This work was featured here:
   [wellcomedbt] [The Hindu]
46. Godbole M, Chandrani P, Gardi N, Dhamne H, Patel K, Yadav N, Gupta S, Badwe R, Dutt A. miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells. Cancer Biology & Therapy. 2017
[READ] [SUMMARY]
   This work was featured here:
   [wellcomedbt] [The Hindu]